Diebold, K., Mudd, T., Hardee, M., Thigpen, H., Espinoza-Gutarra, M., Stasi, A. D., Salzman, D., Mohty, R., Bhatia, R., Jamy, O. (2025). Improved outcomes with low-dose hypomethylating agent plus venetoclax as post-transplant maintenance in patients undergoing reduced intensity conditioning allogeneic hematopoietic stem cell transplantation for myeloid malignancies. Blood. https://doi.org/10.1182/blood-2025-4261